Tag: endocrine system

Incorporation of a nonintensive fitness intervention for women with obesity into a standard fertility treatment program could be cost-effective, a new analysis finds. Financial data for the Canadian Fit-for-Fertility program were presented March 20 at the virtual ENDO 2021: The Endocrine Society Annual Meeting by Matea Belan, PhD, of the division of endocrinology at the University

Incorporation of a nonintensive fitness intervention for women with obesity into a standard fertility treatment program could be cost-effective, a new analysis finds. Financial data for the Canadian Fit-for-Fertility program were presented March 20 at the virtual ENDO 2021: The Endocrine Society Annual Meeting by Matea Belan, PhD, of the division of endocrinology at the University

A 2.4-mg weekly injection of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide led to a clinically meaningful 5% loss in weight for roughly two thirds of patients with both overweight/obesity and type 2 diabetes, researchers report. These findings from the Semaglutide Treatment Effect in People With Obesity 2 (STEP 2) trial, one of four phase